Zdenek Berger - Publications

Affiliations: 
Mayo Clinic Jacksonville, Jacksonville, FL, United States 

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Berger Z, Perkins S, Ambroise C, Oborski C, Calabrese M, Noell S, Riddell D, Hirst WD. Tool compounds robustly increase turnover of an artificial substrate by glucocerebrosidase in human brain lysates. Plos One. 10: e0119141. PMID 25763858 DOI: 10.1371/Journal.Pone.0119141  0.315
2014 Shen W, Henry AG, Paumier KL, Li L, Mou K, Dunlop J, Berger Z, Hirst WD. Inhibition of glucosylceramide synthase stimulates autophagy flux in neurons. Journal of Neurochemistry. 129: 884-94. PMID 24494600 DOI: 10.1111/Jnc.12672  0.356
2013 Li L, Nadanaciva S, Berger Z, Shen W, Paumier K, Schwartz J, Mou K, Loos P, Milici AJ, Dunlop J, Hirst WD. Human A53T α-synuclein causes reversible deficits in mitochondrial function and dynamics in primary mouse cortical neurons. Plos One. 8: e85815. PMID 24392030 DOI: 10.1371/Journal.Pone.0085815  0.353
2013 Paumier KL, Sukoff Rizzo SJ, Berger Z, Chen Y, Gonzales C, Kaftan E, Li L, Lotarski S, Monaghan M, Shen W, Stolyar P, Vasilyev D, Zaleska M, D Hirst W, Dunlop J. Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's disease. Plos One. 8: e70274. PMID 23936403 DOI: 10.1371/Journal.Pone.0070274  0.371
2010 Berger Z, Smith KA, Lavoie MJ. Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylation. Biochemistry. 49: 5511-23. PMID 20515039 DOI: 10.1021/Bi100157U  0.352
2007 Berger Z, Roder H, Hanna A, Carlson A, Rangachari V, Yue M, Wszolek Z, Ashe K, Knight J, Dickson D, Andorfer C, Rosenberry TL, Lewis J, Hutton M, Janus C. Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 3650-62. PMID 17409229 DOI: 10.1523/Jneurosci.0587-07.2007  0.638
2006 Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, ... ... Berger Z, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 442: 916-9. PMID 16862116 DOI: 10.1038/Nature05016  0.622
2006 Davies JE, Berger Z, Rubinsztein DC. Oculopharyngeal muscular dystrophy: Potential therapies for an aggregate-associated disorder International Journal of Biochemistry and Cell Biology. 38: 1457-1462. PMID 16530457 DOI: 10.1016/J.Biocel.2006.01.016  0.405
2006 Ravikumar B, Berger Z, Vacher C, O'Kane CJ, Rubinsztein DC. Rapamycin pre-treatment protects against apoptosis. Human Molecular Genetics. 15: 1209-16. PMID 16497721 DOI: 10.1093/Hmg/Ddl036  0.347
2006 Berger Z, Davies JE, Luo S, Pasco MY, Majoul I, O'Kane CJ, Rubinsztein DC. Deleterious and protective properties of an aggregate-prone protein with a polyalanine expansion Human Molecular Genetics. 15: 453-465. PMID 16371423 DOI: 10.1093/Hmg/Ddi460  0.384
2006 Berger Z, Ravikumar B, Menzies FM, Oroz LG, Underwood BR, Pangalos MN, Schmitt I, Wullner U, Evert BO, O'Kane CJ, Rubinsztein DC. Rapamycin alleviates toxicity of different aggregate-prone proteins. Human Molecular Genetics. 15: 433-42. PMID 16368705 DOI: 10.1093/Hmg/Ddi458  0.481
2006 Berger Z, Lewis J, Andorfer C, Yue M, Rosenberry T, Hutton M. P1-087: Identification of toxic tau species Alzheimer's & Dementia. 2: S120-S120. DOI: 10.1016/J.Jalz.2006.05.462  0.628
2006 Lewis J, Zehr C, Andorfer C, Eriksen J, Knight J, Yue M, Robinson T, Berger Z, Hanna A, Dickson DW, Janus C, McGowan E, Hutton M. O4-05-01: Methods of cell death and recovery in the rTg4510 and iP301L inducible mouse models of tauopathy Alzheimer's & Dementia. 2: S84-S84. DOI: 10.1016/J.Jalz.2006.05.327  0.577
2006 Eriksen J, Zehr C, Berger Z, Robinson T, Lewis J, Hutton M. P3-293: Tau clearance through protein degradation pathways Alzheimer's & Dementia. 2: S461-S462. DOI: 10.1016/J.Jalz.2006.05.1562  0.634
2005 Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, Pasco M, Cook LJ, Rubinsztein DC. Lithium induces autophagy by inhibiting inositol monophosphatase Journal of Cell Biology. 170: 1101-1111. PMID 16186256 DOI: 10.1083/Jcb.200504035  0.338
2005 Berger Z, Ttofi EK, Michel CH, Pasco MY, Tenant S, Rubinsztein DC, O'Kane CJ. Lithium rescues toxicity of aggregate-prone proteins in Drosophila by perturbing Wnt pathway Human Molecular Genetics. 14: 3003-3011. PMID 16141285 DOI: 10.1093/Hmg/Ddi331  0.399
2005 Ravikumar B, Acevedo-Arozena A, Imarisio S, Berger Z, Vacher C, O'Kane CJ, Brown SD, Rubinsztein DC. Dynein mutations impair autophagic clearance of aggregate-prone proteins. Nature Genetics. 37: 771-6. PMID 15980862 DOI: 10.1038/Ng1591  0.448
2004 Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF, Duden R, O'Kane CJ, Rubinsztein DC. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nature Genetics. 36: 585-95. PMID 15146184 DOI: 10.1038/Ng1362  0.44
2003 Ravikumar B, Sarkar S, Berger Z, Rubinsztein DC. The roles of the ubiquitin-proteasome and autophagy-lysosome pathways in Huntington's disease and related conditions Clinical Neuroscience Research. 3: 141-148. DOI: 10.1016/S1566-2772(03)00056-2  0.46
Show low-probability matches.